angiotensin ii has been researched along with cyclosporine in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 36 (44.44) | 18.2507 |
2000's | 33 (40.74) | 29.6817 |
2010's | 11 (13.58) | 24.3611 |
2020's | 1 (1.23) | 2.80 |
Authors | Studies |
---|---|
Hardy, KJ; Phillips, PA; Potocnik, SJ | 1 |
Callís, L; Fortuny, G; Nieto, J; Vila, A | 1 |
Huss, R; Locher, R; Vetter, W | 1 |
Grabensee, B; Heering, P; Kreuzpaintner, G; Kutkuhn, B; Reinhard, T; Sundmacher, R | 1 |
Bronsther, O; Brown, MR; Crum, R; Dominic, W; Fairchild, R; Fernandez, R; Ward, D | 1 |
Bunke, M; Martin, A; Wilder, L | 1 |
Berkenboom, G; Brékine, D; Fontaine, J; Gulbis, B; Unger, P | 1 |
Auch-Schwelk, W; Duske, E; Fleck, E; Hess, B; Hildebrandt, AG; Klein, U; Regitz-Zagrosek, V; Steffen, C | 1 |
Fogo, A; Hunley, TE; Kon, V | 1 |
Cambar, J; L'Azou, B; Lakhdar, B; Potier, M | 1 |
Andreis, PG; Gottardo, G; Malendowicz, LK; Markowska, A; Mazzocchi, G; Neri, G; Nussdorfer, GG; Tortorella, C | 1 |
Aldred, K; Hardy, KJ; Phillips, PA; Rolls, KA | 1 |
Ballardie, FW; Chalmers, RJ; Edwards, BD; Lawson, RS; Mitchell, DM; O'Driscoll, JB; Smith, RJ; Testa, HJ | 1 |
Conde, M; Gualberto, A; Sobrino, F | 1 |
Baumelou, A; Bletry, O; Deray, G; Faucher, C; Godeau, P; Jacobs, C; Rieu, P | 1 |
Auch-Schwelk, W; Betz, M; Duske, E; Fleck, E; Hink, U; Unkelbach, M | 1 |
Ballardie, FW; Chalmers, RJ; Edwards, BD; Lawson, RS; O'Driscoll, J; Testa, HJ | 1 |
Auch-Schwelk, W; Bossaller, C; Fleck, E; Götze, S; Thelen, J | 1 |
Clozel, JP; Fischli, W; Ménard, J | 1 |
Brown, MR; De Nicola, L; Gabbai, FB; Thomson, SC; Wead, LM | 1 |
Bokemeyer, D; Drechsler, S; Friedrichs, U; Kramer, HJ; Meyer-Lehnert, H | 1 |
Braith, RW; Davis, GL; Mills, RM; Wilcox, CS; Wood, CE | 1 |
Eaton, DC; Ling, BN; Ma, H; Matsunaga, H | 1 |
Coutie, WJ; Lang, CC; Struthers, AD; Sturrock, ND | 1 |
Alpers, CE; Andoh, TF; Bennett, WM; Burdmann, EA; Couser, WG; Franceschini, N; Hugo, C; Pichler, RH; Shankland, SJ; Young, BA | 1 |
Hodge, EE; Inman, SR; Novick, AC; Stowe, NT | 1 |
Aparicio, M; Cambar, J; Combe, C; Forpomès, O | 1 |
Andoh, TF; Bennett, WM; Shihab, FS; Tanner, AM | 1 |
Aguilar, M; Andujar, M; Arrebola, F; del Moral, RG; García-Chicano, MJ; Gómez-Morales, M; Guillén, M; Masseroli, M; Nogales, FF; O'Valle, F; Olmo, A; Ramírez, C | 1 |
Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE | 1 |
Abbott, KL; Boss, V; Murphy, TJ; Pavlath, GK; Wang, XF | 1 |
Aguilar, M; Arrebola, F; Asensio, C; Becerra, P; Carvia, R; Del Moral, RG; Guillén, M; O'Valle, F; Olmo, A; Osuna, A; Reguero, ME | 1 |
Afanasjeva, GV; Avdonin, PV; Cottet-Maire, F; Lhote, P; Loktionova, SA; Ruegg, UT | 1 |
Woo, KT | 1 |
Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Schmidt, F | 1 |
Fu, M; Liu, N; Pang, Y; Su, J; Tang, C; Xu, S; Zhang, J | 1 |
Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
Brunner, HR; Murat, A; Pedrazzini, T; Pellieux, C | 1 |
Grabs, R; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M | 1 |
Field, MJ; Johnson, DW; Pollock, CA; Qi, W; Saunders, HJ; Vesey, DA | 1 |
Fu, MG; Jiang, ZS; Liu, NK; Pang, YZ; Tang, CS; Wang, XH | 1 |
Ahn, HJ; Bang, BK; Kim, J; Kim, SK; Kim, WY; Kim, YO; Kim, YS; Park, JH; Shin, MJ; Yang, CW | 1 |
Buttrick, PM; Geenen, DL; Goldspink, PH; Kimball, VA; McKinney, RD | 1 |
Levi, M; Moons, AH; Peters, RJ | 1 |
Kellems, RE; Wen, HY; Xia, Y | 1 |
Eguchi, S; Frank, GD; Inagami, T; Motley, ED; Saito, S; Utsunomiya, H | 1 |
Andoh, TF; Bennett, WM; Isaac, J; Shihab, FS; Yi, H | 1 |
Ahn, HJ; Bang, BK; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW; Yoon, SA | 1 |
Ha, H; Kim, H; Kim, MS; Kim, YS; Lee, JH; Park, J; Park, K; Seo, J | 1 |
Ahonen, J; Finckenberg, P; Ganten, D; Inkinen, K; Louhelainen, M; Luft, F; Merasto, S; Mervaala, E; Müller, D; Vapaatalo, H | 1 |
Abe, Y; Fukui, T; Hitomi, H; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Nishiyama, A; Rahman, M; Shokoji, T; Yao, L; Zhang, GX | 1 |
Bens, M; Chang, CT; Vandewalle, A; Wu, MS; Yang, CW | 1 |
Fu, M; Liu, N; Pang, Y; Tang, C; Xu, S; Zhang, J | 1 |
Hou, FF; Wang, L; Zhang, GH; Zhang, X | 1 |
Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R | 1 |
Ahn, KO; Choi, YH; Chung, BH; Ito, S; Kim, J; Li, C; Lim, SW; Sugawara, A; Sun, BK; Yang, CW; Yang, JH; Yoon, KH | 1 |
Ahn, KO; Bang, BK; Choi, BS; Kim, J; Kim, JS; Kim, JY; Kim, YS; Li, C; Lim, SW; Yang, CW; Yang, HJ | 1 |
Bartoli, E; Bergamasco, L; Castello, L; Letizia, C; Sainaghi, PP | 2 |
Han, Z; Xiang, J; Yang, Y; Zhang, K | 1 |
Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M | 1 |
Chen, LM; Chu, CH; Huang, CY; Kuo, WW; Lee, SD; Lin, JA; Liu, CJ; Liu, JY; Lu, MC; Wu, CH | 1 |
Epting, T; Gordjani, N; Hartmann, K; Nitschke, R; Sandqvist, A | 1 |
Cibulskyte, D; Frøkiaer, J; Hansen, HE; Hørlyck, A; Madsen, M; Marcussen, N; Mortensen, J; Pedersen, M | 1 |
Ishikawa, A; Kitamura, T; Ohta, N; Ozono, S; Tanaka, M | 1 |
Ahn, KO; Ghee, JY; Kim, J; Kim, JY; Kim, SH; Li, C; Lim, SW; Yang, CW; Yang, HJ | 1 |
Alba, G; Chacón, P; El Bekay, R; Jiménez, J; Martín-Nieto, J; Oliván, J; Pintado, E; Ramos, E; Reyes, ME; Sobrino, F; Vega, A | 1 |
Fan, Y; Shang, MH; Yuan, WJ; Zhang, SJ; Zhang, Z | 1 |
Chen, J; Cheng, M; Ding, X; Han, F; Le, Y; Xu, L; Zhang, L; Zhu, X | 1 |
Ghee, JY; Han, DH; Kim, S; Kobori, H; Kuro-o, M; Ohashi, N; Piao, S; Song, JH; Yang, CW; Yoon, HE | 1 |
Borlak, J; Niehof, M | 1 |
Cucchiari, D; Graziani, G; Ponticelli, C | 1 |
Cornaire, E; Galichon, P; Hertig, A; Mesnard, L; Rondeau, E; Vandermeersch, S; Vittoz, N; Xu-Dubois, YC | 1 |
Arbonés, ML; Campanero, MR; Esteban, V; García-Redondo, AB; Jiménez-Borreguero, LJ; Méndez-Barbero, N; Novensá, L; Redondo, JM; Roqué, M; Salaices, M; Vila, L | 1 |
Montezano, AC; Touyz, RM; White, M | 1 |
Periasamy, S; Rao, S; Senthilkumar, K; Subramani, T | 1 |
Bin, J; Cao, S; Chen, C; Huang, X; Kitakaze, M; Li, G; Li, X; Liao, Y; Shen, L; Xu, D; Xuan, W; Zhang, J | 1 |
Huang, X; Lin, Y; Qian, D; Tan, J; Wang, Y; Xia, J; Zhang, X | 1 |
El-Din, MM; El-Mas, MM; Elmallah, AI; Khedr, MM; Nasser, SA; Sabra, R | 1 |
Alp-Yıldırım, Fİ; Bekpinar, S; Cibali, E; Gultepe, S; Karaca, E; Olgac, V; Uydes-Doğan, BS; Uysal, M; Yamakoğlu, S | 1 |
Bachmann, S; Hu, J; Mutig, K; Xu, Y | 1 |
4 review(s) available for angiotensin ii and cyclosporine
Article | Year |
---|---|
Role of growth factors in mesangial cell ion channel regulation.
Topics: Angiotensin II; Animals; Calcium; Chloride Channels; Cyclosporine; Diabetic Nephropathies; Endothelins; Furosemide; Glomerular Mesangium; Growth Substances; Humans; Insulin; Ion Channels; Ion Transport; Models, Biological; Receptors, Angiotensin | 1995 |
Current therapeutic strategies in glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cyclophosphamide; Cyclosporine; Dipyridamole; Glomerulonephritis; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Remission Induction; Steroids; Tacrolimus; Vasodilator Agents; Warfarin | 1999 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
Hypertension in kidney transplant recipients.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Cardiovascular Diseases; Cyclosporine; Diuretics; Glucocorticoids; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Life Style; Renal Artery Obstruction; Vascular Resistance | 2011 |
3 trial(s) available for angiotensin ii and cyclosporine
Article | Year |
---|---|
Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.
Topics: Adult; Aged; Angiotensin II; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Psoriasis; Renal Circulation; Renin-Angiotensin System; Risk Factors | 1994 |
Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.
Topics: Adult; Angiotensin II; Cross-Over Studies; Cyclosporine; Diuretics; Double-Blind Method; Furosemide; Humans; Hypertension, Renal; Male; Renal Circulation; Renin-Angiotensin System; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Case-Control Studies; Cyclosporine; Female; Humans; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Losartan; Male; Middle Aged; Polycythemia; Prospective Studies; Receptor, Angiotensin, Type 1; Safety; Uric Acid | 2009 |
74 other study(ies) available for angiotensin ii and cyclosporine
Article | Year |
---|---|
Human resistance artery reactivity is altered by liver transplantation and treatment with cyclosporin A.
Topics: Adipose Tissue; Angiotensin II; Arginine Vasopressin; Arteries; Cyclosporine; Humans; In Vitro Techniques; Liver Neoplasms; Liver Transplantation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Vascular Resistance; Vasoconstriction | 1992 |
Effect of cyclosporin A on proteinuria in patients with Alport's syndrome.
Topics: Adolescent; Angiotensin II; Basement Membrane; Child; Creatinine; Cyclosporine; Female; Humans; Kidney Function Tests; Kidney Glomerulus; Liver Function Tests; Male; Nephritis, Hereditary; Proteinuria | 1992 |
Potentiation of vascular smooth muscle cell activity by cyclosporin A.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Cyclosporine; DNA; Drug Synergism; Female; Inositol Phosphates; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Thymidine | 1991 |
[Kidney function of patients with healthy kidneys during cyclosporin treatment].
Topics: Acid-Base Equilibrium; Adult; Aldosterone; Angiotensin II; Corneal Transplantation; Creatinine; Cyclosporine; Female; Humans; Kidney; Kidney Function Tests; Liver Transplantation; Male; Renin; Water-Electrolyte Balance | 1991 |
Neuroendocrinology of chronic renal failure and renal transplantation.
Topics: Adult; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cyclosporine; Epinephrine; Furosemide; Humans; Hypertension, Renal; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone; Neurosecretory Systems; Norepinephrine; Prospective Studies; Radioimmunoassay; Renal Dialysis; Water-Electrolyte Balance | 1991 |
The effect of cyclosporine on agonist-stimulated glomerular and mesangial cell vasodilatory prostaglandin production.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Creatine; Cyclosporine; Dinoprostone; Glomerular Filtration Rate; Glomerular Mesangium; Kidney Glomerulus; Kidney Medulla; Male; Norepinephrine; Prostaglandins; Protein Kinase C; Rats; Rats, Inbred Strains; Vascular Resistance; Vasodilation; Vasodilator Agents | 1991 |
Attenuation of cyclosporine A-induced vascular toxicity by ramipril.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Cyclosporine; Endothelium, Vascular; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phenylephrine; Ramipril; Rats; Rats, Wistar | 1994 |
Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.
Topics: Administration, Oral; Adrenal Cortex; Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cyclosporine; Down-Regulation; Drug Interactions; Imidazoles; Kidney; Lisinopril; Liver; Losartan; Male; Pyridines; Quinolines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Up-Regulation | 1995 |
Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats.
Topics: Angiotensin II; Animals; Cyclosporine; Endothelin Receptor Antagonists; Endothelins; Fibrosis; Kidney Function Tests; Kidney Glomerulus; Male; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction | 1995 |
Image analyser as a tool for the study of in vitro glomerular vasoreactivity.
Topics: Angiotensin II; Animals; Cell Size; Cells, Cultured; Cyclosporine; Glomerular Mesangium; Image Processing, Computer-Assisted; Kidney Glomerulus; Microscopy, Video; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1994 |
Effects of cyclosporine-A on steroid secretion of dispersed rat adrenocortical cells.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Angiotensin II; Animals; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Radioimmunoassay; Rats; Rats, Wistar | 1994 |
Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cyclosporine; Female; Hypertension; In Vitro Techniques; Mesenteric Arteries; Rats; Rats, Wistar; Renin-Angiotensin System; Sensitivity and Specificity; Vascular Resistance; Vasoconstriction | 1994 |
Cyclosporin A antagonizes phenylephrine, oxytocin and angiotensin effects on glucose metabolism in rat thymus lymphocytes.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Calcimycin; Cyclosporine; Dose-Response Relationship, Drug; Fructosediphosphates; Glucose; Glycolysis; Lactates; Lactic Acid; Lymphocytes; Male; Oxytocin; Phenylephrine; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate; Thymus Gland | 1994 |
Medical nephrectomy with CsA and angiotensin II in a case of life-threatening membranous glomerulonephritis.
Topics: Adult; Angiotensin II; Cyclosporine; Glomerulonephritis, Membranous; Humans; Kidney; Male; Nephrectomy; Nephrotic Syndrome | 1994 |
Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Cyclosporine; Heart; Heart Rate; Kidney; Lisinopril; Liver; Male; Organ Size; Quinolines; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasodilation; Vasomotor System; Weight Gain | 1994 |
Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin.
Topics: Adolescent; Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemodynamics; Hormones; Humans; Male; Middle Aged; Nifedipine; Psoriasis; Renal Circulation | 1993 |
Calcium entry blockade may prevent cyclosporin A-induced hypersensitivity to angiotensin II and endothelial dysfunction in the rat aorta.
Topics: Angiotensin II; Animals; Aorta; Cyclosporine; Diltiazem; Endothelium, Vascular; Male; Muscle Contraction; Muscle, Smooth, Vascular; Random Allocation; Rats; Rats, Wistar; Vasodilation | 1993 |
Effects of the blockade of the renin-angiotensin system in cyclosporin-induced hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Antibodies; Cilazapril; Cyclosporine; Female; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Male; Renin; Renin-Angiotensin System; Saimiri | 1993 |
Arginine feeding modifies cyclosporine nephrotoxicity in rats.
Topics: Administration, Oral; Angiotensin II; Animals; Arginine; Capillaries; Cyclosporine; Glomerular Filtration Rate; Hydrostatic Pressure; Kidney; Kidney Glomerulus; Male; Nephrons; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance | 1993 |
Cellular signaling by cyclosporine A in contractile cells: interactions with atrial natriuretic peptide.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Calcium; Cells, Cultured; Cyclosporine; Glomerular Mesangium; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Signal Transduction | 1993 |
Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients.
Topics: Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Case-Control Studies; Cyclosporine; Female; Heart; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Renin-Angiotensin System; Sodium Chloride; Sodium, Dietary; Ventricular Function, Left; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 1996 |
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
Topics: Angiotensin II; Animals; Blood Pressure; Cyclosporine; Cytokines; Immunohistochemistry; Kidney; Kidney Diseases; Male; Osteopontin; Rats; Rats, Sprague-Dawley; Sialoglycoproteins | 1995 |
Cyclosporine A enhances the vascular reactivity to angiotensin II in the renal microcirculation in rodents.
Topics: Angiotensin II; Animals; Arterioles; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Hydronephrosis; Male; Microcirculation; Rats; Rats, Wistar; Renal Circulation; Vasodilation | 1996 |
Cyclosporin-A- and angiotensin-II-induced vasoreactivity in isolated glomeruli and cultured mesangial cells, 4 and 24 h after renal mass reduction: role of vasodilatory prostaglandins.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Cells, Cultured; Cyclosporine; Glomerular Filtration Rate; Glomerular Mesangium; In Vitro Techniques; Indomethacin; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nephrectomy; Prostaglandins; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors; Vasoconstriction; Vasodilation | 1997 |
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.
Topics: Angiotensin II; Animals; Blotting, Northern; Cyclosporine; Extracellular Matrix Proteins; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 1997 |
Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
Topics: Angiotensin II; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Chronic Disease; Creatinine; Cyclosporine; Gene Expression Regulation; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Urea | 1997 |
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling | 1998 |
The cyclosporin A-sensitive nuclear factor of activated T cells (NFAT) proteins are expressed in vascular smooth muscle cells. Differential localization of NFAT isoforms and induction of NFAT-mediated transcription by phospholipase C-coupled cell surface
Topics: Angiotensin II; Animals; Becaplermin; Calcium; Cells, Cultured; Colforsin; Cyclosporine; DNA-Binding Proteins; Gene Expression Regulation; Genes, Reporter; GTP-Binding Proteins; Immunohistochemistry; Muscle, Smooth, Vascular; NFATC Transcription Factors; Nuclear Proteins; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thrombin; Transcription Factors; Type C Phospholipases | 1998 |
Role of P-glycoprotein in chronic cyclosporine nephrotoxicity and its relationship to intrarenal angiotensin II deposits.
Topics: Angiotensin II; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Creatinine; Cyclosporine; Fibrosis; Immunosuppressive Agents; Kidney; Kidney Cortex; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley | 1998 |
Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells.
Topics: Angiotensin II; Calcineurin Inhibitors; Calcium; Cells, Cultured; Cyclosporine; Cytosol; Humans; Immunosuppressive Agents; Ion Transport; Muscle, Smooth, Vascular; Receptors, Angiotensin; Up-Regulation | 1999 |
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Diseases; Humans; Hypertension, Renal; Interleukin-6; Kidney; Male; Monocytes; Myocardium; Neutrophils; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Binding; Rats; Renin | 2000 |
Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cell Division; Cells, Cultured; Cyclosporine; DNA; Fibroblasts; Fura-2; Hyperplasia; Losartan; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 1999 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension.
Topics: Angiotensin II; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Enzyme Activation; Hypertension, Renovascular; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Protein Kinase C | 2000 |
New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Losartan; Male; Premedication; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterotopic | 2000 |
Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cell Division; Cell Survival; Cells, Cultured; Collagen; Culture Media, Conditioned; Cyclosporine; Cytokines; Enalaprilat; Fibroblasts; Humans; Immunosuppressive Agents; Kidney Cortex; Kidney Tubules, Proximal; Nephritis, Interstitial | 2000 |
[Involvement of calcineurin-dependent signal pathway in the angiotensin II-induced cardiac myocyte hypertrophy].
Topics: Angiotensin II; Animals; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocardium; Rats; Signal Transduction | 1999 |
Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Cyclosporine; Diet, Sodium-Restricted; Epidermal Growth Factor; Fibrosis; Immunohistochemistry; In Situ Nick-End Labeling; Kidney Glomerulus; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System | 2001 |
Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats.
Topics: Angiotensin II; Animals; Blotting, Northern; Body Weight; Calcineurin; Calcium; Cardiomegaly; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hypertrophy; Myocardium; Organ Size; Rats; Rats, Wistar; RNA; Signal Transduction; Up-Regulation | 2001 |
Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation.
Topics: Angiotensin II; Calcineurin; Cell Line; Cyclosporine; DNA-Binding Proteins; Embryo Implantation; Gene Expression Regulation; Humans; Losartan; NFATC Transcription Factors; Nuclear Proteins; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Trophoblasts | 2002 |
Cyclosporin A inhibits angiotensin II-induced c-Jun NH(2)-terminal kinase activation but not protein synthesis in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Anisomycin; Aorta, Thoracic; Cells, Cultured; Cyclosporine; Enzyme Activation; Enzyme Inhibitors; Immunosuppressive Agents; JNK Mitogen-Activated Protein Kinases; Leucine; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Tacrolimus | 2002 |
Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cyclosporine; Disease Models, Animal; Enalapril; Endothelial Growth Factors; Extracellular Matrix Proteins; Gene Expression; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Kidney Diseases; Losartan; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2002 |
Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Body Weight; Chronic Disease; Cyclosporine; Drug Synergism; Fibrosis; Gene Expression; Immunosuppressive Agents; Kidney; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Effect of carvedilol alone or in the presence of cyclosporine on the migration of vascular smooth muscle cell of rat.
Topics: Angiotensin II; Animals; Carbazoles; Carvedilol; Cells, Cultured; Chemotaxis; Cyclosporine; Immunosuppressive Agents; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Propanolamines; Rats; Rats, Sprague-Dawley | 2003 |
Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.
Topics: Angiotensin II; Animals; Blood Pressure; Calcineurin; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Cyclosporine; Everolimus; Gene Expression Regulation; Heart; Humans; Immediate-Early Proteins; Immunosuppressive Agents; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Kidney; Male; Organisms, Genetically Modified; Rats; Rats, Sprague-Dawley; Renin; Sirolimus; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Blood Pressure; Creatinine; Cyclic N-Oxides; Cyclosporine; Hypertension; Immunosuppressive Agents; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Spin Labels; Tetrazoles; Valine; Valsartan | 2003 |
Cyclosporin increases the density of angiotensin II subtype 1 (AT1) receptors in mouse medullary thick ascending limb cells.
Topics: Angiotensin II; Animals; Calcium; Cell Survival; Cells, Cultured; Cyclosporine; Immunosuppressive Agents; Kidney Medulla; Male; Mice; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Rats; Rats, Wistar; RNA, Messenger | 2001 |
[Role of activation of renin angiotensin system in cyclosporine A nephropathy].
Topics: Angiotensin II; Animals; Cyclosporine; Immunosuppressive Agents; Kidney; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger | 2003 |
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis | 2004 |
Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.
Topics: Angiotensin II; Animals; Apoptosis; Cyclosporine; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Islets of Langerhans; Kidney; Osteopontin; Pancreatic Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sialoglycoproteins; Thiazolidinediones; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Topics: Angiotensin II; Animals; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Osteopontin; Propylene Glycols; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Pathways of glomerular toxicity of cyclosporine-A: an "in vitro" study.
Topics: Angiotensin I; Angiotensin II; Animals; Cyclosporine; Endothelin-1; Female; Kidney Glomerulus; Oligopeptides; Organ Culture Techniques; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Time Factors | 2005 |
Effects of cyclosporine A on angiotensin II-induced cardiomyocyte hypertrophy in neonatal rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Proto-Oncogene Proteins c-fos; Rats | 2005 |
The CARI guidelines. Prevention of progression of kidney disease.
Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy | 2006 |
Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
Topics: Angiotensin II; Animals; Antibodies; Apoptosis; bcl-Associated Death Protein; Calcineurin; Calcineurin Inhibitors; Caspase 3; Caspase 9; Caspases; Cell Line; Cyclosporine; Cytochromes c; DNA Fragmentation; Drug Synergism; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Models, Biological; Myoblasts, Cardiac; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptor, IGF Type 2; Signal Transduction; Tacrolimus; Transfection | 2006 |
Cyclosporin A stimulates apical Na+/H+ exchange in LLC-PK1/PKE20 proximal tubular cells.
Topics: Angiotensin II; Animals; Blotting, Northern; Calcineurin Inhibitors; Calcium; Cyclosporine; Fluorescent Dyes; Fura-2; Hydrogen-Ion Concentration; Immunosuppressive Agents; LLC-PK1 Cells; Protein Kinase C; RNA, Messenger; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Swine; Vasoconstrictor Agents | 2006 |
Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Biopsy; Blood Flow Velocity; Blood Pressure; Cyclosporine; Disease Models, Animal; Female; Follow-Up Studies; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Magnetic Resonance Imaging; Renal Circulation; Swine; Telmisartan; Treatment Outcome | 2007 |
Prevention of interstitial fibrosis of renal allograft by angiotensin II blockade.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cyclosporine; Female; Fibrosis; Humans; Immunosuppressive Agents; Kidney Transplantation; Losartan; Male; Middle Aged; Postoperative Complications | 2006 |
Influence of angiotensin II on expression of toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy.
Topics: Angiotensin II; Animals; Cyclosporine; Dendritic Cells; Immunity, Innate; Kidney; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha | 2007 |
Rac2 GTPase activation by angiotensin II is modulated by Ca2+/calcineurin and mitogen-activated protein kinases in human neutrophils.
Topics: Angiotensin II; Animals; Calcineurin; Calcium; Cell Membrane; Cyclosporine; Enzyme Activation; Enzyme Inhibitors; Humans; Mice; Mitogen-Activated Protein Kinases; Neutrophils; Phosphatidylinositol 3-Kinases; rac GTP-Binding Proteins; RAC2 GTP-Binding Protein; Reactive Oxygen Species; Signal Transduction | 2007 |
In vitro effect of cyclosporine-A on angiotensins secretion by glomerular cells.
Topics: Angiotensin I; Angiotensin II; Animals; Cyclosporine; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Female; Immunosuppressive Agents; Kidney Glomerulus; Oligopeptides; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Time Factors; Tissue Culture Techniques; Up-Regulation | 2008 |
Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.
Topics: Adult; Aged; Angiotensin II; Cyclosporine; Endothelial Cells; Female; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Renin; Renin-Angiotensin System | 2008 |
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Angiotensin II; Animals; Blotting, Western; Chronic Disease; Cyclosporine; Deoxyguanosine; Disease Models, Animal; Glucuronidase; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Klotho Proteins; Male; Mice; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Vasoconstrictor Agents | 2011 |
HNF4alpha dysfunction as a molecular rational for cyclosporine induced hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Binding Sites; Carcinoma, Hepatocellular; Cell Line, Tumor; Computational Biology; Consensus Sequence; Cyclosporine; Gene Expression Regulation; Hepatocyte Nuclear Factor 4; Humans; Hypertension; Immunosuppressive Agents; NFATC Transcription Factors; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Transcription, Genetic | 2011 |
Epithelial phenotypic changes detect cyclosporine in vivo nephrotoxicity at a reversible stage.
Topics: Acute Kidney Injury; Angiotensin II; Animals; beta Catenin; Biomarkers; Collagen Type III; Cyclosporine; Epithelial Cells; Epithelial-Mesenchymal Transition; HSP47 Heat-Shock Proteins; Immunosuppressive Agents; Kidney; Male; Models, Animal; Phenotype; Rats; Rats, Sprague-Dawley; Snail Family Transcription Factors; Transcription Factors; Up-Regulation; Vimentin | 2011 |
Regulator of calcineurin 1 mediates pathological vascular wall remodeling.
Topics: Aneurysm; Angiotensin II; Animals; Aorta; Calcineurin; Calcium-Binding Proteins; Cell Movement; Coronary Restenosis; Cyclosporine; Gene Expression Regulation; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Smooth, Vascular; NFATC Transcription Factors; Rats; Rats, Wistar; Signal Transduction | 2011 |
Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.
Topics: Angiotensin II; Animals; Calcineurin; Cell Proliferation; Cyclosporine; Fibroblasts; Immunosuppressive Agents; Inflammation; Mitogen-Activated Protein Kinases; Myocardium; Phosphorylation; Rats; Rats, Inbred WKY; Signal Transduction; Tacrolimus | 2012 |
Expression of angiotensin II and its receptors in cyclosporine-induced gingival overgrowth.
Topics: Adult; Angiotensin II; Angiotensinogen; Case-Control Studies; Cells, Cultured; Chronic Periodontitis; Cyclosporine; Female; Fibroblasts; Gingival Overgrowth; Humans; Immunosuppressive Agents; Male; Middle Aged; Receptors, Angiotensin; Renin-Angiotensin System; Young Adult | 2013 |
Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Topics: Adenoviridae; Angiotensin II; Animals; Animals, Newborn; Aorta; Atrial Natriuretic Factor; Calcineurin; Calpain; Cardiomegaly; Constriction, Pathologic; Cyclosporine; Gene Expression Regulation; Genetic Vectors; Glycoproteins; Imidazoles; Mice; Muscle Proteins; Myocytes, Cardiac; Myosin Heavy Chains; Nuclear Proteins; Primary Cell Culture; Protein Transport; Rats; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Tetrazoles | 2014 |
An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
Topics: Adenosine A1 Receptor Agonists; Angiotensin II; Animals; Calcineurin; Cyclosporine; Enzyme Inhibitors; In Vitro Techniques; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Rats; RNA, Messenger; Signal Transduction | 2014 |
Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Animals; Aorta; Atrasentan; Baroreflex; Blood Pressure; Captopril; Cyclosporine; Hypertension; Indomethacin; Losartan; Male; Naphthalenes; Nitric Oxide Synthase Type III; Nitroprusside; Oligopeptides; Phenylephrine; Piperidines; Propionates; Pyrrolidines; Rats; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2016 |
Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin-angiotensin system.
Topics: Angiotensin II; Animals; Aorta; Cyclosporine; Cytoprotection; Dose-Response Relationship, Drug; Gene Expression Regulation; Kidney; Male; NADPH Oxidase 4; Rats; Rats, Wistar; Renin-Angiotensin System; Resveratrol; RNA, Messenger; Vasoconstriction; Vasodilation | 2019 |
Angiotensin II receptor blockade alleviates calcineurin inhibitor nephrotoxicity by restoring cyclooxygenase 2 expression in kidney cortex.
Topics: Angiotensin II; Animals; Calcineurin Inhibitors; Cyclooxygenase 2; Cyclosporine; Kidney; Kidney Cortex; Rats; Receptors, Angiotensin | 2021 |